ストックスクリーナーアプリを入手
15.85
4.63%
-0.77
アフターアワーズ：
15.84
-0.010
-0.06%
前日終値:
$16.62
開ける：
$15.34
24時間の取引高:
2.27M
Relative Volume:
1.54
時価総額：
$1.49B
収益：
$796.00M
当期純損益:
$-136.49M
株価収益率:
-7.5837
EPS:
-2.09
ネットキャッシュフロー:
$-64.24M
1週間 パフォーマンス:
-7.20%
1か月 パフォーマンス:
-21.65%
6か月 パフォーマンス:
-57.72%
1年 パフォーマンス:
-63.12%
1日の値動き範囲:
$15.17
$16.35
1週間の範囲:
$15.17
$17.29
52週間の値動き範囲:
$15.17
$48.24
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
名前
Tandem Diabetes Care Inc
セクター
電話
858-366-6900
住所
12400 HIGH BLUFF DRIVE, San Diego, CA
TNDM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
15.85 | 1.49B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
133.22 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.96 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
392.05 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.00 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.19 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-16 | 開始されました | Truist | Hold |
| 2025-04-10 | 開始されました | Mizuho | Neutral |
| 2025-03-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-03-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-10-04 | 開始されました | Goldman | Neutral |
| 2024-10-02 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-22 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-04-29 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | アップグレード | Stifel | Hold → Buy |
| 2023-08-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-05-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-04-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-08-09 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 開始されました | Wells Fargo | Overweight |
| 2020-07-31 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-07-06 | アップグレード | Citigroup | Neutral → Buy |
| 2020-06-18 | 繰り返されました | Raymond James | Outperform |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-06 | 開始されました | Raymond James | Outperform |
| 2020-02-04 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 開始されました | Guggenheim | Buy |
| 2019-10-04 | アップグレード | UBS | Neutral → Buy |
| 2019-05-17 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-13 | 開始されました | SVB Leerink | Outperform |
| 2019-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2019-03-05 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-02-27 | 繰り返されました | Lake Street | Buy |
| 2018-11-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-09-26 | 繰り返されました | Piper Jaffray | Overweight |
すべてを表示
Tandem Diabetes Care Inc (TNDM) 最新ニュース
Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management - MSN
How To Trade (TNDM) - news.stocktradersdaily.com
Digital Diabetes Management Market 2025Growth in Apps, - openPR.com
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities - FinancialContent
What Does Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Share Price Indicate? - Yahoo Finance
Tandem Diabetes Care’s SWOT analysis: stock faces growth hurdles amid market shifts - Investing.com Nigeria
TNDM: Truist Securities Initiates Coverage with Hold Rating | TN - GuruFocus
TNDM: Truist Securities Initiates Coverage with Hold Rating | TNDM Stock News - GuruFocus
10 Best Stocks to Buy For Beginners Now - Insider Monkey
Truist bullish on diabetes companies citing potential market growth - Seeking Alpha
Truist initiates Tandem Diabetes Care stock with hold rating By Investing.com - Investing.com Canada
Tandem Diabetes (TNDM) Receives Hold Rating from Truist | TNDM S - GuruFocus
Truist Initiates Tandem Diabetes Care at Hold With $24 Price Target - MarketScreener
Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions - simplywall.st
Tandem, Abbott team on insulin delivery with glucose-ketone sensor - MedTech Dive
Abbott to pair glucose-ketone sensor with Tandem's insulin pumps - Modern Healthcare
Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor - MarketScreener
Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued By Stocktwits - Investing.com India
Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued - Asianet Newsable
Diabetes partnerships abound ahead of ADA - BioWorld MedTech
Tandem Diabetes at Goldman Sachs Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Transcript : Tandem Diabetes Care, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener
Tandem Diabetes (TNDM) Partners with Abbott for Innovative Diabe - GuruFocus
Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor - Seeking Alpha
Tandem Diabetes Care Announces Agreement With Abbott For Integration Of Automated Insulin Delivery Systems With Future Glucose-Ketone Sensor - marketscreener.com
Tandem Diabetes, Abbott to Merge Insulin Pump with Future Glucose-Ketone Sensor - Medical Product Outsourcing
Abbott (ABT) Partners with Tandem Diabetes for Advanced Diabetes Management Solutions | ABT Stock News - GuruFocus
Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor | TNDM Stock News - GuruFocus
3 Reasons to Sell TNDM and 1 Stock to Buy Instead - Yahoo Finance
Transcript : Tandem Diabetes Care, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 03 - MarketScreener
Tandem to pay Roche $36M in patent dispute settlement - MSN
Tandem Diabetes Care: A Barbell Bet On A High-Stakes Turnaround (NASDAQ:TNDM) - Seeking Alpha
(TNDM) Long Term Investment Analysis - news.stocktradersdaily.com
Tandem Diabetes at Jefferies: Expanding Market Horizons By Investing.com - Investing.com Canada
How the Non-Invasive Drug Delivery Device Market Will Evolve - openPR.com
Do You Believe in the Long-Term Growth Potential of Tandem Diabetes Care (TNDM)? - Insider Monkey
Roche settles UPC dispute over insulin distribution technology - JUVE Patent
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges - Benzinga
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Recommendation of “Hold” from Analysts - Defense World
Tandem Diabetes Care Inc (TNDM) Shares Gap Down to $20.62 on May 30 - GuruFocus
Tandem Diabetes Care (TNDM) Up 6.5% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Contrasting Tandem Diabetes Care (NASDAQ:TNDM) and PolyPid (NASDAQ:PYPD) - Defense World
Cetera Investment Advisers Acquires 981 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Reflecting On Healthcare Technology Stocks’ Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) - Yahoo Finance
Tandem Diabetes and Roche Reach a Patent Settlement - MSN
How the (TNDM) price action is used to our Advantage - news.stocktradersdaily.com
Tandem Diabetes, Roche enter patent settlement agreement - Yahoo Finance
Tandem Diabetes Care (TNDM) Settles Patent Dispute with Roche - GuruFocus
Should Tandem Diabetes Stock Stay in Your Portfolio Now? - MSN
Tandem Diabetes Care Inc (TNDM) 財務データ
収益
当期純利益
現金流量
EPS
Tandem Diabetes Care Inc (TNDM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER |
Jun 16 '25 |
Option Exercise |
0.00 |
7,414 |
0 |
32,609 |
| Cha Myoungil | Director |
Jun 16 '25 |
Option Exercise |
0.00 |
1,749 |
0 |
13,699 |
| Malagueira Joao Paulo Falcao | Director |
Jun 16 '25 |
Option Exercise |
0.00 |
1,749 |
0 |
13,699 |
| Sodhi Rajwant | Director |
May 22 '25 |
Option Exercise |
20.64 |
4,387 |
90,548 |
15,521 |
| McGroddy-Goetz Kathleen | Director |
May 22 '25 |
Option Exercise |
20.64 |
4,387 |
90,548 |
17,853 |
| Cha Myoungil | Director |
May 22 '25 |
Option Exercise |
20.64 |
4,387 |
90,548 |
11,950 |
| ROBERTSON REBECCA B | Director |
May 22 '25 |
Option Exercise |
20.64 |
4,387 |
90,548 |
13,783 |
| Howell Peyton R | Director |
May 22 '25 |
Option Exercise |
20.64 |
4,387 |
90,548 |
21,077 |
| TWOMEY CHRISTOPHER J | Director |
May 22 '25 |
Option Exercise |
20.64 |
4,387 |
90,548 |
15,675 |
| Malagueira Joao Paulo Falcao | Director |
May 22 '25 |
Option Exercise |
20.64 |
4,387 |
90,548 |
11,950 |
0.32%
0.55%
大文字化:
|
ボリューム (24 時間):